Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: Harry Ehrlich who wrote (1226)	3/3/1998 1:27:00 PM
From: D.Right	Read Replies (1) \| Respond to of 2173

Dear Harry: The market is always right I was told many times but I still make mistakes by taking the wrong side. Two bright spots if you want to look at them. First, JNJ just gave AMLN about $150m gift for free, which is more than the market cap of AMLN now. Second, AMLN said it will market pramlintide for type I in the European market one year earlier (file first half next year, but I don't know how long the approval process will take), which will have money coming in to support operation from there. Additional positive is still the 75% number they mentioned at the H&Q conference. But these positive won't take the pain away from the price falls we have been taking lately. Hopefully, this is the end of bad news season. D.Right